Ovarian Primary Peritoneal Cancer
Primary Peritoneal Cancer originates from the peritoneal lining and closely resembles ovarian cancer in presentation.
Patients may experience abdominal bloating, discomfort, early satiety, and pelvic pain. Diagnosis involves imaging, biopsy, and sometimes laparoscopy. Treatment usually includes cytoreductive surgery to remove visible tumors, followed by chemotherapy and targeted therapies to prevent recurrence.
Causes and Risk Factors
This cancer is influenced by genetic and environmental factors.
- BRCA gene mutations: Increase susceptibility similar to ovarian cancer
- Family history of ovarian or breast cancer
- Older age and hormonal factors
Symptoms and Clinical Features
Patients often present with:
- Abdominal bloating and distension
- Pelvic pain and discomfort: Persistent or intermittent
- Early satiety, nausea, and fatigue
- Changes in bowel habits
Treatment Options for Primary Peritoneal Cancer
Treatment focuses on tumor removal and reducing recurrence risk.
- Cytoreductive surgery: Removal of visible tumors from the peritoneum
- Chemotherapy to target residual disease
- Targeted therapy: For cancers with specific molecular markers
Why Choose Us for Ovarian Primary Peritoneal Cancer
CureU Healthcare offers advanced gynecologic oncology expertise, precision cytoreductive surgery, multidisciplinary chemotherapy management, and comprehensive follow-up care.
Conclusion
Primary Peritoneal Cancer can be effectively managed with early diagnosis and coordinated surgical and medical therapy. CureU Healthcare provides complete patient-centered care.
